Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12226417
APP PUB NO 20230218621A1
SERIAL NO

18101986

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides treatment of fatty liver disease using a class of pyrimidinedione cyclohexyl compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CORCEPT THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Belanoff, Joseph K Menlo Park, US 47 581
Hunt, Hazel Storrington, GB 61 739
Meijer, Onno C Leiden, NL 4 22
van, den Heuvel José Leiden, NL 4 22

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 18, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 18, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 18, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00